HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

IMPACT THERAP-B

13.030

+1.75015.51%

Volume:21.16M

Turnover:277.71M

Market Cap:3.68B

PE:-10.06

High:14.240

Open:11.370

Low:11.300

Close:11.280

52wk High:47.980

52wk Low:10.310

Shares:282.46M

HK Float Shares:282.46M

Volume Ratio:2.81

T/O Rate:7.49%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-1.295

ROE:--

ROA:-40.35%

PB:4.05

PE(LYR):-10.06

PS:26.58

Loading ...

Overview Company News Filings

Major Milestone Achieved: European Regulators Endorse Sepalna as Impact Therapeutics-B (07630) Surges 15.51% at Close

Impact Therapeutics Gets Positive EMA Opinion for Ovarian Cancer Drug

MT Newswires Live

Impact Therapeutics - Senaparib Submitted to European Commission for Final Marketing Authorization Decision

THOMSON REUTERS

Impact Therapeutics and Pharmanovia Announce Positive Chmp Opinion for Senaparib, as a Potential First-Line Maintenance Treatment of Advanced High-Grade Epithelial Ovarian, Fallopian Tube, and Primary Peritoneal Cancer

THOMSON REUTERS

Morning Market Recap: Hong Kong Stocks Edge Higher, AI Drug Development Sector Surges

IMPACT THERAP-B Surges Over 20% in Morning Trading Following Stock Connect Inclusion and Insider Buying

IMPACT Therapeutics Delivers 317% Revenue Surge and Narrows Interim Loss on Robust Senaparib Sales and IPO Proceeds

Bulletin Express

IMPACT THERAP-B Shares Added to Shanghai-Shenzhen Stock Connect Programs

IMPACT Therapeutics Added to Both Shanghai- and Shenzhen-Hong Kong Stock Connect Lists

Bulletin Express

Impact Therapeutics Added to Shanghai, Shenzhen Stock Connect Eligible List from Sept. 7, 2026

IMPACT THERAP-B Joins Stock Connect, Opening Doors for Mainland Investors

Insider Purchase: Cai Suixiong Boosts Stake in Impact Therapeutics with HK$1.46 Million Deal

IMPACT THERAP-B: Sui Xiong Cai Acquires Shares, Long Position Rises to 6.56%

Hong Kong Stocks Fall on Thursday, Amid Bond Selloff, Rate Fears; HUTCHMED Jumps 14%

MT Newswires Live

Hong Kong Stock Market Update: IMPACT THERAP-B (07630) Surges Nearly 13% on Core Drug Growth and Index Inclusion Prospects

Impact Therapeutics CEO Cai Lifts Stake to 6.56% After Buying 100,000 Shares at Hk$14.61 Each

IMPACT Therapeutics CEO Increases Personal Stake to 6.56% via HK$1.46 Million On-Market Purchase

Bulletin Express

Impact Therapeutics - CEO Purchases 100,000 Ordinary Shares at Hk$14.6105 Per Share

THOMSON REUTERS

Impact Therapeutics Says Senaparib EU Marketing Application Under EMA Review, Approval Eyed in 2H 2026

Impact Therapeutics FY26 H1 Net Loss Narrows 29.5% to RMB 90.81 Million; Revenue Rises to RMB 105.19 Million

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigermarketf.com/stock/07630/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"07630","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"07630\",,,,,undefined,":{"symbol":"07630","market":"HK","secType":"STK","nameCN":"IMPACT THERAP-B","latestPrice":13.03,"timestamp":1789718910895,"preClose":11.28,"halted":0,"volume":21157400,"delay":0,"changeRate":0.15514184397163122,"floatShares":282461530,"shares":282461530,"eps":-1.294715,"marketStatus":"Not Yet Opened","change":1.75,"latestTime":"09-18 16:08:30","open":11.37,"high":14.24,"low":11.3,"amount":277714272,"amplitude":0.260638,"askPrice":13.04,"askSize":5200,"bidPrice":13.03,"bidSize":38000,"shortable":0,"etf":0,"ttmEps":-1.052,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789954200000},"marketStatusCode":0,"adr":0,"listingDate":1778601600000,"exchange":"SEHK","adjPreClose":11.28,"openAndCloseTimeList":[[1789695000000,1789704000000],[1789707600000,1789718400000]],"volumeRatio":2.8096879747164647,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"07630\",,,,,undefined,":{"symbol":"07630","floatShares":282461530,"roa":"-40.35%","roe":"--","lyrEps":-1.294715,"volumeRatio":2.8096879747164647,"shares":282461530,"dividePrice":0,"high":14.24,"amplitude":0.260638,"preClose":11.28,"low":11.3,"week52Low":10.31,"pbRate":"4.05","psRate":"26.58","week52High":47.98,"institutionHeld":0,"latestPrice":13.03,"committee":0.759259,"eps":-1.294715,"divideRate":0,"volume":21157400,"delay":0,"ttmEps":-1.052,"open":11.37,"prevYearClose":20.1,"prevWeekClose":13.03,"prevMonthClose":14.46,"prevQuarterClose":36.08,"fiveDayClose":12.9,"twentyDayClose":13.46,"sixtyDayClose":36.98},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/07630\",params:#limit:5,,,undefined,":[{"date":"2026-08-31","symbol":"07630","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1788139800000,"name":null,"time":"","dateTimestamp":1788105600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"07630\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"07630\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":1,"updateTime":1782230400000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/07630\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"07630","date":"2026-09-18","current":-12.385932,"percent":0.573034,"low":-34.323153,"twenty":-29.977617,"median":-13.665771,"eighty":-10.535977,"high":-8.821219,"avg":-18.669128,"sd":9.252146,"marketCap":3680473735},"quantilePoints":[{"date":"2026-05-15","current":-32.36994,"twenty":-32.973318,"median":-32.357426,"eighty":-26.127101,"marketCap":11057651805},{"date":"2026-05-22","current":-30.548005,"twenty":-32.354923,"median":-30.958502,"eighty":-28.393426,"marketCap":10411425401},{"date":"2026-05-29","current":-32.218614,"twenty":-32.294393,"median":-30.958502,"eighty":-30.148817,"marketCap":11018988687},{"date":"2026-06-05","current":-29.849738,"twenty":-32.359929,"median":-31.257987,"eighty":-30.148817,"marketCap":10223633112},{"date":"2026-06-12","current":-29.369689,"twenty":-32.33377,"median":-30.548005,"eighty":-29.705347,"marketCap":10052410732},{"date":"2026-06-18","current":-29.78235,"twenty":-32.303072,"median":-30.338658,"eighty":-29.742668,"marketCap":10218109810},{"date":"2026-06-26","current":-29.297581,"twenty":-32.241427,"median":-30.11999,"eighty":-29.607619,"marketCap":10002701008},{"date":"2026-07-03","current":-16.26247,"twenty":-32.218614,"median":-29.994357,"eighty":-29.297581,"marketCap":5556442415},{"date":"2026-07-10","current":-15.780707,"twenty":-31.493905,"median":-29.916258,"eighty":-25.475578,"marketCap":5385220035},{"date":"2026-07-17","current":-11.297625,"twenty":-31.022068,"median":-29.816044,"eighty":-15.922995,"marketCap":3869073471},{"date":"2026-07-24","current":-9.271485,"twenty":-30.958502,"median":-29.609087,"eighty":-15.602668,"marketCap":3175898995},{"date":"2026-07-31","current":-10.646015,"twenty":-30.630104,"median":-29.369689,"eighty":-13.307417,"marketCap":3653664669},{"date":"2026-08-07","current":-10.047131,"twenty":-30.493855,"median":-29.24895,"eighty":-10.58915,"marketCap":3454825776},{"date":"2026-08-14","current":-10.299125,"twenty":-30.36699,"median":-25.475578,"eighty":-10.316459,"marketCap":3545960269},{"date":"2026-08-21","current":-10.772628,"twenty":-30.33128,"median":-16.418396,"eighty":-10.292557,"marketCap":3717182649},{"date":"2026-08-28","current":-12.490535,"twenty":-30.224959,"median":-15.896725,"eighty":-10.316459,"marketCap":4310937679},{"date":"2026-09-04","current":-14.62831,"twenty":-30.072679,"median":-15.691688,"eighty":-10.353511,"marketCap":4403575252},{"date":"2026-09-11","current":-12.087934,"twenty":-30.026033,"median":-14.57977,"eighty":-10.495083,"marketCap":3643753737},{"date":"2026-09-18","current":-12.193817,"twenty":-29.977617,"median":-13.665771,"eighty":-10.535977,"marketCap":3680473735}],"updateTime":1789913053408},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"07630\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1114201316","title":"Major Milestone Achieved: European Regulators Endorse Sepalna as Impact Therapeutics-B (07630) Surges 15.51% at Close","url":"https://stock-news.laohu8.com/highlight/detail?id=1114201316","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114201316?lang=en_us&edition=fundamental","pubTime":"2026-09-18 19:28","pubTimestamp":1789730898,"startTime":"0","endTime":"0","summary":"Shares of innovative drugmaker Impact Therapeutics-B (07630) experienced a strong rally on September 18, closing at HK$13.03, a rise of HK$1.75 or 15.51% from the previous trading day.The stock...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07630","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668928894","title":"Impact Therapeutics Gets Positive EMA Opinion for Ovarian Cancer Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2668928894","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668928894?lang=en_us&edition=fundamental","pubTime":"2026-09-18 19:14","pubTimestamp":1789730092,"startTime":"0","endTime":"0","summary":"Impact Therapeutics  said the European Medicines Agency's Committee for Medicinal Products for Human Use adopted a positive opinion recommending approval of Senaparib as a maintenance treatment for advanced ovarian, fallopian tube and primary peritoneal cancer.The recommendation is based mainly on results from the Phase III FLAMES trial, the company said in a Friday Hong Kong bourse filing. The drug will now be submitted to the European Commission for a final decision. If approved, Senaparib will be authorized for marketing across European Union member states and European Economic Area countries.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["07630","LENZ","EPV","BK4139","BK4539","BK4007","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668940382","title":"Impact Therapeutics - Senaparib Submitted to European Commission for Final Marketing Authorization Decision","url":"https://stock-news.laohu8.com/highlight/detail?id=2668940382","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668940382?lang=en_us&edition=fundamental","pubTime":"2026-09-18 18:48","pubTimestamp":1789728491,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260918:nFWN45A09L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","07630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668947267","title":"Impact Therapeutics and Pharmanovia Announce Positive Chmp Opinion for Senaparib, as a Potential First-Line Maintenance Treatment of Advanced High-Grade Epithelial Ovarian, Fallopian Tube, and Primary Peritoneal Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2668947267","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668947267?lang=en_us&edition=fundamental","pubTime":"2026-09-18 18:39","pubTimestamp":1789727951,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260918:nFWN4590Z6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["07630","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199026319","title":"Morning Market Recap: Hong Kong Stocks Edge Higher, AI Drug Development Sector Surges","url":"https://stock-news.laohu8.com/highlight/detail?id=1199026319","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199026319?lang=en_us&edition=fundamental","pubTime":"2026-09-18 12:09","pubTimestamp":1789704542,"startTime":"0","endTime":"0","summary":"Hong Kong's benchmark Hang Seng Index climbed 0.67% in mid-session trading, advancing 164 points to reach 24,768, while the Hang Seng Tech Index jumped 1.74%. Morning turnover on the Hong Kong...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0264606111.USD","HSImain","603127","LU0972618739.USD","LU0862451837.USD","07666","LU1366334651.USD","03033","BK1544","513600","BK1592","LU1831875114.USD","02228","BK1161","BK1506","07552","09067","LU0463099449.HKD","LU0791591158.USD","02833","07200","00992","HK0000320223.HKD","BK1526","HSTECH","LU2242644610.SGD","IE0003895053.USD","07300","03423","BK1149","LU0791590937.USD","HK0000320264.USD","01879","09088","LU1366334578.USD","06658","83115","IE00B0JY6N72.USD","LU0862451753.SGD","LU1808992512.USD","LU0244354667.USD","LU0048580855.USD","LU0181495838.USD","07500","03067","BK1193","LNVGY","LU0320764755.SGD","LU0672654166.SGD","09903","LU0828237940.HKD","03032","BK1574","00100","02837","BK1117","LU0348825331.USD","03115","LU0417516902.SGD","LU0052756011.USD","LU0348827113.USD","LU1267930227.SGD","02701","BK1141","BK1583","03088","HK0000306701.USD","BK1183","BK1237","LU0890818403.SGD","LU0543330483.HKD","BK1617","80992","LU0310800965.SGD","BK1163","IE0034224299.USD","BK1198","LU0049112450.USD","01300","82800","BK1576","LU0128525689.USD","01818","IE0032431581.USD","09115","LU0140636845.USD","LU0572940350.SGD","HHImain","03696","BK1607","TCHI","LU1785774172.SGD","03419","LU0572939691.SGD","07630","03037","LU1046422090.SGD","02800","HTImain","LU1235295612.USD","LU0128522157.USD","LU0326950275.SGD","07226","HSI","LU0561508036.HKD","600547","01787","02656","02670","HK0000306685.HKD","06127","LU0029875118.USD","300077","LU1188198961.HKD","02142","MCHmain","LU0370786039.SGD","BK1197","03417"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125581582","title":"IMPACT THERAP-B Surges Over 20% in Morning Trading Following Stock Connect Inclusion and Insider Buying","url":"https://stock-news.laohu8.com/highlight/detail?id=1125581582","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125581582?lang=en_us&edition=fundamental","pubTime":"2026-09-18 10:50","pubTimestamp":1789699816,"startTime":"0","endTime":"0","summary":"IMPACT THERAP-B (07630) surged more than 26% during intraday trading. At the time of writing, the stock was up 20.30% at HK$13.57, with trading turnover reaching HK$149 million.Starting September 7,...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07630","BK1161","SURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136065551","title":"IMPACT Therapeutics Delivers 317% Revenue Surge and Narrows Interim Loss on Robust Senaparib Sales and IPO Proceeds","url":"https://stock-news.laohu8.com/highlight/detail?id=1136065551","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136065551?lang=en_us&edition=fundamental","pubTime":"2026-09-14 08:23","pubTimestamp":1789345417,"startTime":"0","endTime":"0","summary":"IMPACT Therapeutics (IMPACT), a PRC-based synthetic-lethality oncology specialist, reported interim results for the six months ended 30 June 2026 that show rapid commercial traction for its PARP...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"IMPACT Therapeutics Delivers 317% Revenue Surge and Narrows Interim Loss on Robust Senaparib Sales and IPO Proceeds","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197643588","title":"IMPACT THERAP-B Shares Added to Shanghai-Shenzhen Stock Connect Programs","url":"https://stock-news.laohu8.com/highlight/detail?id=1197643588","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197643588?lang=en_us&edition=fundamental","pubTime":"2026-09-07 12:30","pubTimestamp":1788755416,"startTime":"0","endTime":"0","summary":"IMPACT THERAP-B (07630) has officially announced its inclusion in the eligible securities lists for both the Shanghai-Hong Kong Stock Connect and Shenzhen-Hong Kong Stock Connect programs.According...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","161027","07630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126511990","title":"IMPACT Therapeutics Added to Both Shanghai- and Shenzhen-Hong Kong Stock Connect Lists","url":"https://stock-news.laohu8.com/highlight/detail?id=1126511990","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126511990?lang=en_us&edition=fundamental","pubTime":"2026-09-07 12:20","pubTimestamp":1788754853,"startTime":"0","endTime":"0","summary":"On 7 September 2026, IMPACT Therapeutics, Inc. (IMPACT Therapeutics) announced that its H shares have been admitted to the list of eligible securities under the Shanghai-Hong Kong Stock Connect and...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665396024","title":"Impact Therapeutics Added to Shanghai, Shenzhen Stock Connect Eligible List from Sept. 7, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2665396024","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665396024?lang=en_us&edition=fundamental","pubTime":"2026-09-07 12:08","pubTimestamp":1788754103,"startTime":"0","endTime":"0","summary":"Impact Therapeutics added to Shanghai, Shenzhen Stock Connect eligible list from Sept. 7, 2026Impact Therapeutics’ H shares will be added to the eligible stock lists for Shanghai-Hong Kong Stock Conne","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nNDL5FXGKT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07630","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193162585","title":"IMPACT THERAP-B Joins Stock Connect, Opening Doors for Mainland Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=1193162585","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193162585?lang=en_us&edition=fundamental","pubTime":"2026-09-04 20:10","pubTimestamp":1788523816,"startTime":"0","endTime":"0","summary":"The Shanghai Stock Exchange announced after market close on September 4th that, in accordance with the relevant provisions of the \"Shanghai-Hong Kong Stock Connect Implementation Measures,\" IMPACT...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FLHK","07630","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171709484","title":"Insider Purchase: Cai Suixiong Boosts Stake in Impact Therapeutics with HK$1.46 Million Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=1171709484","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171709484?lang=en_us&edition=fundamental","pubTime":"2026-09-03 19:34","pubTimestamp":1788435272,"startTime":"0","endTime":"0","summary":"Data from the Hong Kong Stock Exchange reveals that on September 1, Cai Suixiong increased his holding in IMPACT THERAP-B (07630) by 100,000 shares at a price of HK$14.6105 per share, totaling...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EWH","07630","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121401584","title":"IMPACT THERAP-B: Sui Xiong Cai Acquires Shares, Long Position Rises to 6.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=1121401584","media":"HK Disclosure","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121401584?lang=en_us&edition=fundamental","pubTime":"2026-09-03 17:50","pubTimestamp":1788429051,"startTime":"0","endTime":"0","summary":"On September 1, 2026, Sui Xiong Cai bought 100,000 shares of IMPACT THERAP-B (07630) at an average of HKD 14.6105 per share, involving about HKD 1.46 million.Prior to the acquisition, Sui Xiong Cai's...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664820481","title":"Hong Kong Stocks Fall on Thursday, Amid Bond Selloff, Rate Fears; HUTCHMED Jumps 14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664820481","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664820481?lang=en_us&edition=fundamental","pubTime":"2026-09-03 16:53","pubTimestamp":1788425601,"startTime":"0","endTime":"0","summary":"Hong Kong stocks closed lower on Thursday as rising bond yields and oil prices increased concerns over U.S. interest rates and monetary policy.The Hang Seng Index fell 97.90 points, or 0.4%, to close at 25,213.31, while the Hang Seng China Enterprises Index dropped 64.86 points, or 0.8%, to 8,385.24.Global bond prices fell, with U.S. Treasury yields reaching their highest levels since 2023, while higher oil prices added to inflation concerns.Investors also remained cautious amid renewed U.S.-Iran attacks and awaited Friday's U.S. payrolls report for clues on the Federal Reserve's next move. Markets have raised the odds of a 25-basis-point rate hike this month to about 62% from 37% a week ago, according to a Reuters report.In corporate developments, HUTCHMED   jumped more than 14% after agreeing to grant a GSK subsidiary worldwide rights, excluding Mainland China, Hong Kong, Macau and Taiwan, to develop and commercialize its experimental cancer drug HMPL-A830 for up to $1.30 billion.Sep","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1587","09115","BK1161","03115","07200","513600","83115","BK1588","07500","02833","07300","00013","03037","03419","BK1191","82800","07630","MCHmain","MHImain","HHImain","02800","HSI","HSTECH","HCM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102771982","title":"Hong Kong Stock Market Update: IMPACT THERAP-B (07630) Surges Nearly 13% on Core Drug Growth and Index Inclusion Prospects","url":"https://stock-news.laohu8.com/highlight/detail?id=1102771982","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102771982?lang=en_us&edition=fundamental","pubTime":"2026-09-03 15:18","pubTimestamp":1788419895,"startTime":"0","endTime":"0","summary":"Shares of IMPACT THERAP-B (07630) jumped nearly 13% in Hong Kong trading, last up 11.14% at HK$14.87 with turnover reaching HK$5.15 million.In a morning announcement, the company disclosed that its...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VXUS","KCAI","BK4588","BK4585","BK1161","07630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664131847","title":"Impact Therapeutics CEO Cai Lifts Stake to 6.56% After Buying 100,000 Shares at Hk$14.61 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=2664131847","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664131847?lang=en_us&edition=fundamental","pubTime":"2026-09-03 08:33","pubTimestamp":1788395580,"startTime":"0","endTime":"0","summary":"Impact Therapeutics CEO Cai lifts stake to 6.56% after buying 100,000 shares at HK$14.61 eachCEO Sui Xiong Cai bought 100,000 ordinary shares in the open market, lifting his stake to 6.56%.Purchase pr","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nNDL1nSkS9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Impact Therapeutics CEO Cai Lifts Stake to 6.56% After Buying 100,000 Shares at Hk$14.61 Each","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07630","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120376512","title":"IMPACT Therapeutics CEO Increases Personal Stake to 6.56% via HK$1.46 Million On-Market Purchase","url":"https://stock-news.laohu8.com/highlight/detail?id=1120376512","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120376512?lang=en_us&edition=fundamental","pubTime":"2026-09-03 08:23","pubTimestamp":1788394986,"startTime":"0","endTime":"0","summary":"IMPACT Therapeutics, Inc. (IMPACT THERAP-B) disclosed that Executive Director and Chief Executive Officer Dr. Sui Xiong Cai acquired 100,000 ordinary shares in the open market at an average price of...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664842249","title":"Impact Therapeutics - CEO Purchases 100,000 Ordinary Shares at Hk$14.6105 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2664842249","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664842249?lang=en_us&edition=fundamental","pubTime":"2026-09-03 08:02","pubTimestamp":1788393730,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nFWN44U19D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","07630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663730330","title":"Impact Therapeutics Says Senaparib EU Marketing Application Under EMA Review, Approval Eyed in 2H 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2663730330","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663730330?lang=en_us&edition=fundamental","pubTime":"2026-08-31 16:33","pubTimestamp":1788165237,"startTime":"0","endTime":"0","summary":"Impact Therapeutics says senaparib EU marketing application under EMA review, approval eyed in 2H 2026Impact Therapeutics’ senaparib ovarian-cancer maintenance filing with the EMA was accepted in Augu","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nNDL4HjK0z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07630","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663073702","title":"Impact Therapeutics FY26 H1 Net Loss Narrows 29.5% to RMB 90.81 Million; Revenue Rises to RMB 105.19 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2663073702","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663073702?lang=en_us&edition=fundamental","pubTime":"2026-08-31 16:33","pubTimestamp":1788165221,"startTime":"0","endTime":"0","summary":"Impact Therapeutics FY26 H1 net loss narrows 29.5% to RMB 90.81 million; revenue rises to RMB 105.19 millionImpact Therapeutics reported revenue of RMB 105.19 million, up more than quadrupled from a y","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nNDL7fVJfp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","07630"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":1,"totalSize":92,"code":"91000000","status":"200"}]}}